Neogen
NEOG
$12.14
Share price
1.51%
Change (1 day)
-27.82%
Change (1 year)
Operating Margin for Neogen (NEOG)
Operating Margin as of April 2024 (TTM): -2.68%
According to Neogen's latest financial reports and stock price the company's current Operating Margin is -2.68%. At the end of 2022 the company had an Operating Margin of 11.42%.
Operating Margin history for Neogen from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 11.42% | -28.92% |
| 2021 | 16.07% | -7.08% |
| 2020 | 17.29% | -1.84% |
| 2019 | 17.62% | -3.55% |
| 2018 | 18.26% | -0.95% |
| 2017 | 18.44% | 6.71% |
| 2016 | 17.28% | -6.08% |
| 2015 | 18.40% | 5.77% |
| 2014 | 17.39% | -12.26% |
| 2013 | 19.82% | 7.43% |
| 2012 | 18.45% | -9.57% |
| 2011 | 20.41% | 4.95% |
| 2010 | 19.44% | 6.75% |
| 2009 | 18.21% | 0.85% |
| 2008 | 18.06% | 12.13% |
| 2007 | 16.11% | -3.5% |
| 2006 | 16.69% | 17.49% |
| 2005 | 14.21% | 2.75% |
| 2004 | 13.83% | -11.62% |
| 2003 | 15.64% | 7.88% |
| 2002 | 14.50% | 3.91% |
| 2001 | 13.96% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | -628.73% | 🇺🇸 USA |
 Becton Dickinson BDX | 9.46% | -452.99% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | 25.53% | -1,052.61% | 🇺🇸 USA |
 Illumina ILMN | -94.58% | 3,429.10% | 🇺🇸 USA |
 Danaher DHR | 26.34% | -1,082.84% | 🇺🇸 USA |
 PerkinElmer
PKI | 14.13% | -627.24% | 🇺🇸 USA |
 Pacific Biosciences
PACB | -218.42% | 8,050.00% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 16.31% | -708.58% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.